Add this result to my export selection omalizumab 75mg, 150mg solution for injection (Xolair) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 June 2011 Indication: Add-on therapy to improve asthma control. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection omalizumab 150mg powder and solvent for injection (Xolair) Source: Scottish Medicines Consortium - SMC (Remove filter) 15 January 2007 Indication: Asthma Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection ombitasvir / paritaprevir ritonavir (Viekirax) and dasabuvir (Exviera) Source: Scottish Medicines Consortium - SMC (Remove filter) 08 June 2015 Indication: Ombitasvir/paritaprevir/ritonavir (Viekirax®) for use in combination with dasabuvir (Exviera®) with or without ribavirin for the treatment of genotype 1 chronic hepatitis C (CHC) in... Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection osimertinib (Tagrisso) Source: Scottish Medicines Consortium - SMC (Remove filter) 13 February 2017 Indication: The treatment of adult patients with locally advanced or metastatic epidermal growth factor receptor (EGFR) T790M mutation-positive non-small-cell lung cancer (NSCLC). Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection opicapone (Ongentys) Source: Scottish Medicines Consortium - SMC (Remove filter) 09 October 2017 Indication: Adjunctive therapy to preparations of levodopa / DOPA decarboxylase inhibitors in adult patients with Parkinson's disease and end-of-dose motor fluctuations who cannot be stabilised on... Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Oxaliplatin 50mg, 100mg powder for intravenous infusion (Eloxatin®) Source: Scottish Medicines Consortium - SMC (Remove filter) 07 November 2005 Indication: Adjuvant treatment of stage III (Dukes' C) colon cancer Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection oseltamivir (Tamiflu) Source: Scottish Medicines Consortium - SMC (Remove filter) 07 March 2016 Indication: Treatment of influenza in children aged <1 year including full term neonates who present with symptoms typical of influenza, when influenza virus is circulating in the community. Efficacy... Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection Pemetrexed 500mg infusion (Alimta®) Source: Scottish Medicines Consortium - SMC (Remove filter) 08 August 2005 Indication: Chemotherapy-naïve patients with unresectable malignant pleural mesothelioma Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection pemetrexed, 500mg, powder for reconstitution (Alimta) Source: Scottish Medicines Consortium - SMC (Remove filter) 12 February 2007 Indication: Locally advanced or metastatic non-small cell lung cancer. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)
Add this result to my export selection perampanel (Fycompa) Source: Scottish Medicines Consortium - SMC (Remove filter) 10 December 2012 Indication: As adjunctive treatment for partial-onset seizures with or without secondarily generalized seizures in patients with epilepsy aged 12 years and older. Type: Guidance (Add filter) Type: Prescribing and Technical Information (Remove filter)